Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Cerebral Vasospasm
Interventions
DEVICE

NeVa VS

mechanical dilatation

Trial Locations (10)

10029

Mount Sinai Health System, New York

11030

North Shore University Hospital - Northwell, Manhasset

11794

SUNY Stony Brook University, Stony Brook

14204

University of Buffalo, Buffalo

30062

Wellstar Health System, Marietta

32207

Baptist Health System, Jacksonville

37916

Fort Sanders Regional Med Center, Knoxville

77030

Houston Methodist Hospital, Houston

79905

TTUHSC El Paso, El Paso

80113

RIA Neurovascular Clinic, Englewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vesalio

INDUSTRY

NCT03611790 - Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study) | Biotech Hunter | Biotech Hunter